|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,285.00 INR | +0.40% |
|
+1.15% | +12.27% |
| 03/08 | Glenmark Pharmaceuticals Limited, Q1 2027 Earnings Call, Aug 03, 2026 | |
| 31/07 | India's Glenmark Pharma posts higher quarterly profit on strong demand | RE |
| Market Cap | 64TCr 673.41Cr 583.58Cr 546.32Cr 498.48Cr 938.05Cr 953.81Cr 6.41TCr 2.51TCr 32TCr 2.53TCr 2.47TCr 1,07300Cr | P/E 2026 |
44.2x | P/E 2027 * | 27.7x |
|---|---|---|---|---|---|
| Enterprise Value | 60TCr 632.21Cr 547.87Cr 512.9Cr 467.99Cr 880.66Cr 895.46Cr 6.01TCr 2.36TCr 30TCr 2.37TCr 2.32TCr 1,00700Cr | EV / Sales 2026 |
3.51x | EV / Sales 2027 * | 3.74x |
| Free-Float |
51.05% | Yield 2026 |
0.12% | Yield 2027 * | 0.17% |
Last Transcript: Glenmark Pharmaceuticals Limited
| 1 day | +1.07% | ||
| 1 week | +1.83% | ||
| Current month | +2.97% | ||
| 1 month | -0.04% | ||
| 3 months | +1.91% | ||
| 6 months | +13.06% | ||
| Current year | +13.03% |
| 1 week | 2,245 |  | 2,310 |
| 1 month | 2,162 | | 2,326.1 |
| Current year | 1,842 | | 2,474 |
| 1 year | 1,792.6 | | 2,474 |
| 3 years | 722.1 | | 2,474 |
| 5 years | 348.5 | | 2,474 |
| 10 years | 161.65 | | 2,474 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 56 | 01/01/2000 | |
Anurag Mantri
DFI | Director of Finance/CFO | 54 | 27/05/2025 |
Indrajit Bose
PSD | President | - | 15/09/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
Cherylann Pinto
BRD | Director/Board Member | 58 | - |
| Chairman | 56 | 12/05/2011 | |
| Director/Board Member | 85 | 14/08/2009 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.07% | +1.83% | +11.76% | +188.38% | 673.41Cr | |
| -0.39% | -0.51% | +18.99% | +70.17% | 4.89TCr | |
| -2.47% | +3.77% | +55.63% | +121.20% | 4.14TCr | |
| +0.63% | +6.74% | +25.22% | +86.50% | 1.25TCr | |
| +0.10% | +0.29% | -3.84% | +18.41% | 1.24TCr | |
| +1.35% | -0.38% | +30.98% | +136.36% | 908.38Cr | |
| -0.92% | +6.69% | +23.64% | +38.92% | 752.55Cr | |
| -0.12% | +5.00% | +40.26% | -12.95% | 713.71Cr | |
| -1.22% | +4.46% | -25.04% | +29.64% | 588.22Cr | |
| +1.02% | +3.02% | +31.29% | +103.69% | 459.2Cr | |
| Average | -0.15% | +3,736.17% | +20.89% | +78.03% | 1.56TCr | |
| Weighted average by Cap. | -0.75% | +4,976.10% | +27.69% | +84.02% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 15TCr 160.53Cr 139.12Cr 130.23Cr 118.83Cr 223.62Cr 227.38Cr 1.53TCr 598.31Cr 7.66TCr 602.74Cr 589.61Cr 26TCr | 17TCr 176.06Cr 152.57Cr 142.83Cr 130.33Cr 245.25Cr 249.37Cr 1.67TCr 656.2Cr 8.41TCr 661.06Cr 646.65Cr 28TCr |
| Net income | 2.05TCr 22Cr 19Cr 17Cr 16Cr 30Cr 30Cr 204.77Cr 80Cr 1.03TCr 81Cr 79Cr 3.43TCr | 2.31TCr 24Cr 21Cr 20Cr 18Cr 34Cr 34Cr 230.49Cr 90Cr 1.16TCr 91Cr 89Cr 3.86TCr |
| Net Debt | -3.93TCr -41Cr -36Cr -33Cr -30Cr -57Cr -58Cr -391.9Cr -153.55Cr -1.97TCr -154.69Cr -151.32Cr -6.56TCr | -1.45TCr -15Cr -13Cr -12Cr -11Cr -21Cr -21Cr -144.35Cr -57Cr -724.42Cr -57Cr -56Cr -2.42TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 12/26/12 | ₹2,285.00 | +0.40% | 4,48,223 |
| 11/26/11 | ₹2,276.00 | +1.10% | 2,84,670 |
| 10/26/10 | ₹2,251.30 | -1.22% | 2,57,787 |
| 07/26/07 | ₹2,279.10 | +0.40% | 4,37,610 |
| 06/26/06 | ₹2,270.00 | +0.49% | 5,56,267 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- GLENMARK Stock
Select your edition
All financial news and data tailored to specific country editions
